Larson Financial Group’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-64
Closed -$1.85K – 3955
2026
Q2
$1.85K Buy
+64
New +$1.73K ﹤0.01% 3143
2025
Q4
– Sell
-2
Closed -$65 – 3582
2025
Q3
$65 Buy
+2
New +$74 ﹤0.01% 3343

Other funds holding LEGN

Larson Financial Group's LEGN Position: Q3 2026 in Review

Larson Financial Group sold out of Legend Biotech (LEGN) in Q3 2026, closing a stake of 64 shares — an estimated $1.85K sold.

Larson Financial Group first reported a position in LEGN in Q3 2025 and held it in 2 quarters. The position peaked at $1.85K in Q2 2026. 197 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • Larson Financial Group reported no remaining Legend Biotech position as of Q3 2026 after selling out during the quarter.
  • Larson Financial Group sold 64 Legend Biotech shares in Q3 2026, an estimated $1.85K.
  • Larson Financial Group first reported a position in Legend Biotech in Q3 2025 and held it in 2 quarters.
  • Larson Financial Group's Legend Biotech position peaked at $1.85K in Q2 2026.
  • 197 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.